• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(2): e16657.
Published online Feb 4, 2011. doi:  10.1371/journal.pone.0016657
PMCID: PMC3033892

dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes

Christos Ouzounis, Editor

Abstract

Background

MicroRNAs (miRNAs) are short non-coding RNA molecules that act as post-transcriptional regulators and affect the regulation of protein-coding genes. Mostly transcribed by PolII, miRNA genes are regulated at the transcriptional level similarly to protein-coding genes. In this study we focus on human miRNAs. These miRNAs are involved in a variety of pathways and can affect many diseases. Our interest is on possible deregulation of the transcription initiation of the miRNA encoding genes, which is facilitated by variations in the genomic sequence of transcriptional control regions (promoters).

Methodology

Our aim is to provide an online resource to facilitate the investigation of the potential effects of single nucleotide polymorphisms (SNPs) on miRNA gene regulation. We analyzed SNPs overlapped with predicted transcription factor binding sites (TFBSs) in promoters of miRNA genes. We also accounted for the creation of novel TFBSs due to polymorphisms not present in the reference genome. The resulting changes in the original TFBSs and potential creation of new TFBSs were incorporated into the Dragon Database of Polymorphic Regulation of miRNA genes (dPORE-miRNA).

Conclusions

The dPORE-miRNA database enables researchers to explore potential effects of SNPs on the regulation of miRNAs. dPORE-miRNA can be interrogated with regards to: a/miRNAs (their targets, or involvement in diseases, or biological pathways), b/SNPs, or c/transcription factors. dPORE-miRNA can be accessed at http://cbrc.kaust.edu.sa/dpore and http://apps.sanbi.ac.za/dpore/. Its use is free for academic and non-profit users.

Introduction

MicroRNAs (miRNAs) are ~22 nucleotides long non-coding RNAs that in mammals predominantly act as post-transcriptional regulators and affect gene regulation by decreasing transcript levels mainly through the degradation of mRNA [1], [2]. Canonical miRNA biogenesis begins with the transcription of pri-miRNAs by RNA polymerase II [3], [4], [5], which suggests that miRNA genes are controlled through similar regulatory mechanisms as protein-coding genes. Some new evidence shows that some pri-miRNAs are also transcribed by RNA polymerase III [6], [7]. Cleaving of pri-miRNAs through microprocessor complex Drosha (RNase II endonuclease) and DGCR8 (a double-stranded RNA binding protein) results in forming 60~70 nt pre-miRNAs [8], [9]. These are exported into the cytoplasm by Exportin-5 and its co-factor RanGTP [10] and finally cleaved by Dicer, an RNase III endonuclease, which leads to mature miRNAs after strand separation [2], [11].

The effect of miRNAs on mRNA has recently been the focus of several computational studies, e.g. a number of tools have been developed for predicting miRNA targets (see [12] for a review). On the other hand, the transcriptional machinery that controls the transcription of miRNA genes is currently not well understood. Recent efforts to elucidate what causes miRNAs to be transcribed include experimental and computational methods to elucidate the regulatory regions or transcription start sites (TSSs) of the miRNA genes [13], [14], [15], [16], [17] and the effect of transcription factors (TFs) on miRNA gene transcription [18]. miRNAs can be generated from their own transcriptional units (intergenic), or from within a protein-coding host gene (intragenic) [2]. Several miRNAs can be transcribed together as a single pri-miRNA [19], [20], [21] and are thus transcriptionally co-regulated. Reciprocally, a mature miRNA can stem from several locations in the genome, potentially under the control of several promoter regions [2].

Single nucleotide polymorphisms (SNPs) within a DNA sequence are point variations whose least abundant allele is present in at least 1% of the human population [22], [23] and occur throughout the genome. SNPs found in the human population have been linked to the development of diseases and the response of patients to drugs [24], [25], [26]. Those SNPs that appear in the coding regions may or may not change the polypeptide sequence of the encoded protein, so-called synonymous or non-synonymous SNPs, respectively [27]. Also, SNPs can occur in the regulatory and intergenic regions on the DNA. These may affect gene splicing or TF binding [24], [27] and deregulate transcriptional response.

Previously compiled resources related to both SNPs and miRNAs, like the microRNA Target Site (PolymiRTS) database [28] and dbSMR [29], investigate how SNPs affect the binding of miRNAs to their target protein-coding mRNAs and in this manner influence and regulate the translation of the mRNAs (down-stream effects).

Our Dragon Database of Polymorphic Regulation of miRNA genes (dPORE-miRNA) complements the previous studies. We studied promoter regions of human miRNA genes (intergenic as well as intragenic) for the potential effects that SNPs may have due to their overlap with putative TF binding sites (TFBSs) or as a potential cause for the creation of novel TFBSs on positions where no TFBS was mapped. We compiled miRNA gene promoters from several sources and searched for TFBSs that map to them. The identified TFBSs have been overlaid with known SNPs to provide a basis for a comprehensive overview of how the transcriptional machinery that regulates miRNA genes might be affected by SNPs. Work in this direction has previously been done for protein-coding genes [30], [31].

A recent database, miRGen 2.0 [32] focuses on the regulation of miRNAs. For each miRNA, miRGen 2.0 extracts the content of the miRNA promoter in the form of predicted TFBSs. In miRGen 2.0 an SNP is only indicated if it is overlapping with a predicted TFBS. However, no additional information about the potential effects of these SNPs is available in miRGen 2.0. Furthermore, no search interface is provided to search specifically for TFBSs that are influenced by SNPs.

In contrast, our approach elucidates what influences SNPs potentially have on the regulatory machinery via modifying TFBSs or creating new TFBSs as well as the consequences of such changes. The presence of an SNP on a binding site can result in several different effects. Explicitly, an SNP can lead to (1) a loss of the binding site, (2) a change of binding site, meaning that due to the SNP a different TF binds the region or that the same TFs can bind to the site but with a different affinity, (3) a creation of a new binding site in a region where previously no binding site was known, or (4) no change at all.

The dPORE-miRNA database incorporates the information mentioned above. In order to make our database of interest to a wide variety of users, we incorporated miRNA-disease [33], miRNA-target [34], and miRNA-pathway associations. Thus, the starting point for a study with dPORE-miRNA can be a specific miRNA, miRNA target, disease, or biological pathway. Alternatively, data may be queried from the perspective of a specific SNP or TF of interest. In summary, the database provides a user-friendly web interface for the exploration of specific miRNAs, the SNPs that may have influence over transcription initiation and regulation of miRNA genes, and the affected TFBSs in miRNA promoters. To the best of our knowledge, a database resource that provides such a set of information and features does not yet exist.

Methods

All promoter regions are compiled from the human genome build HG18. MiRNA promoter regions have been extracted based on information from [13], [14], [15], [16], [17] and the UCSC Genome browser [35]. We used two methods of promoter extraction. The first method relies on sequence-based promoter regions that have been extracted as they were defined in [14], [15], [17]. The second method uses TSS-based promoter regions, which have been extracted upstream from the TSS positions and cover segments of 5000 bp. Information about the TSS locations has been derived from [13], [16], [35]. Where genomic positions were given in HG17, we have converted them to HG18 using the UCSC liftover program [35] (see Table 1 for detailed numbers of promoters and miRNAs).

Table 1
Promoter sets.

All SNP data has been extracted from the UCSC Table browser according to dbSNP130 [36] from the HG18 track. In total we gathered 18,833,531 SNPs from the resource. From our promoter data (Table 1), we found that 22,315 SNPs could be mapped to miRNA promoter regions. The distribution of various dbSNP classes of the SNPs is shown in Table 2. The number of SNPs in each group of promoter regions is shown in Table 3.

Table 2
SNP class distribution of the 22,315 miRNA promoter SNPs.
Table 3
Number of SNPs per promoter set.

With the BIOBASE MATCH™ program version 8.3 [37], we mapped TFBSs to the individual promoter regions (Table 1) using 220 non-redundant vertebrate BIOBASE TFBS matrix models (BIOBASE Knowledge Library, including TRANSFAC [38]). The vertebrate minimum false positives motif profiles were used. Table 4 shows an overview of the numbers of identified TFBSs and unique motifs (out of 220) in the individual promoter sets.

Table 4
Overview of TFBS predictions for promoter sets.

All SNPs that appear in the promoter regions of miRNA genes have been studied (see Table 4). From these, all SNP effects on TFBSs have been investigated and each pair of SNP-TFBS has been examined in detail as follows:

  1. A region from the promoter comprising of 30 nucleotides upstream and 30 nucleotides downstream around the SNP position was extracted, including the SNP.
  2. Within this region each observed variation of the SNP has been considered and the so modified region searched again for TFBSs with the same method as described above.
  3. The potential SNP effects were recorded for each variation in the form of prediction scores, matching binding motifs, and the loss or gain of binding motifs.

In addition, all SNPs that appear in the promoter region but do not overlap with a TFBS have been examined if they cause the creation of new predicted TFBSs. These newly predicted TFBSs could only be found due to the observed SNP variation. In this way, we catalogued the potential effects of SNPs on TFBSs present within miRNA promoters, as well as those TFBSs introduced by polymorphisms. In this way, one has the possibility to explore four different effects that SNPs may cause (see Table 5).

Table 5
The effect of the SNPs.

Finally, we incorporated important associations between miRNAs and information intended to aid in the interpretation of search results: a/miRNA-to-disease associations from the PhenomiR database [33]; b/miRNA-to-target associations, experimentally verified from the Tarbase database [34]; c/target-to-biological pathway associations from KEGG pathways [39]. In this way we indirectly map associations between miRNAs and biological pathways and enable searching via KEGG pathways in dPORE-miRNA.

Results

Information regarding promoters, miRNAs, SNPs, TFBSs, and the effects of SNPs on TFBSs has been incorporated into a relational MySQL database (version 5.1). To provide the best possible uptime for the database and the web-interface we installed the database at two locations: http://cbrc.kaust.edu.sa/dpore and http://apps.sanbi.ac.za/dpore/. The web-interface allows for searching the database for specific miRNA identifier, miRNAs that are associated to a specific disease, miRNAs that are associated to a specific pathway, or miRNAs that are known to target a mRNA of a specific protein. Regardless of the starting point of the user query, be it miRNA, disease, target, or pathway, a list of miRNAs related to the user query is given. After the miRNA of interest has been selected, the result page summarizes information regarding the miRNA by displaying all disease, pathway and target associations. Additionally, miRNA promoter data is displayed according to the promoter's source (see Table 1). The promoters are linked to the UCSC Genome browser, which includes custom tracks uploaded by dPORE-miRNA. The custom tracks display all SNPs overlapping putative TFBSs. Viewing each promoter in detail on the result-page displays for each SNP the potential effects on the transcriptional regulation of the miRNA gene. An extended view lists all SNPs overlapping binding motifs and the possible effects (see Table 5) on the TFBS due to the SNP. Information about the binding motif, its location and TFs that potentially bind the motif, are also available (see Figure 1). For users requiring information on specific SNPs or TFs, dPORE-miRNA offers the possibility to search according to specific SNP or TF identifiers. In this manner it is possible to decipher what effects a specific SNP may have on the regulation of miRNA genes, or, which miRNA promoters contain a predicted TFBS for a specific TF that is affected by the SNP.

Figure 1
Result page example.

A comprehensive user manual is available on the website and provides an easy walkthrough of dPORE-miRNA.

Discussion

SNPs are known to be associated with a multitude of diseases and, specifically, it has been shown that SNPs in the regulatory regions can affect the binding of TFs or even lead to the complete loss of function of a particular binding site [24]. Similar efforts to catalogue SNPs that might influence the transcription regulation of protein-coding genes led to the compilation of SNP@Promoter [31] and PupaSuite [30] databases.

There is a limited understanding of the regulation of miRNAs. Even less is known about how SNPs may influence this regulation and what consequences such an influence may have on diseases. miRNAs are known to play a role in human diseases through their effect on gene regulation [40], [41], [42], [43]. Approaches implemented in PolyMIRTS [28], and dbSMR [29] try to answer the question on how SNPs affect miRNA binding to miRNA targets. The database miRGen 2.0 [32], on the other hand, shows putative TFBSs in miRNA promoter regions and the overlap of these with SNPs but comes short of providing any information on the consequences that such overlaps may cause. In addition, it is not possible to search specifically for TFBSs that overlap with an SNP. Our dPORE-miRNA database provides answers to the question: ‘What are the potential consequences of the presence of SNPs in the promoter regions of miRNA genes?’ and extends these further to pathways and diseases that considered SNPs may influence. In this way dPORE-miRNA should be of interest to a broad range of users.

dPORE-miRNA contains information on the possible differential regulation of miRNAs in human sub-populations. Moreover, it stores a total of 734 different miRNA-targets. Among these are the products of 30 genes that are known to be implicated in various cancers through missense mutations according to the Sanger Cancer Gene Census [44]. The effect of TF binding on the expression levels of miRNAs has been experimentally shown [45]; on the other hand, there are cases where changes in the promoter composition through SNPs lead to TFBS losses and with that to modified expression levels of the controlled transcriptional unit [24], [27]. By utilizing dPORE-miRNA to extract information about: a/the SNPs that reside in the regulatory regions of miRNAs and b/the potential effects that these SNPs may have on TF binding, the user can gain an insight into potential causes for changes in miRNA expression levels that might aid to explain the differential expression of known oncogenes in cancerous tissue. For example, EGFR is a well-studied cancer gene that is differentially expressed in a number of cancers and is used in clinical settings as a therapeutic target [46], [47], [48]. Human EGFR is targeted by the products of four human miRNA genes (among them hsa-mir-16-2). This miRNA is shown to be ubiquitously expressed among human and rat tissues, and at concentrations greater than any other miRNA [49]. dPORE-miRNA allows for the detailed exploration of SNP-influenced TF binding in the regulatory regions of these miRNA genes, which could unlock valuable information on the expression levels of this important cancer gene. It is know that hsa-mir-16-2 is regulated by STAT5 [50]. dPORE-miRNA documents the loss of a binding site for TF STAT5 in the upstream region of hsa-mir-16-2 through SNP rs60640467, which could have potential consequences for the transcription initiation of the hsa-mir-16-2 gene. This could have effects on the expression of the miRNA target, EGFR, and thus may exert its influence in cancers. This illustrates a possibility to use dPORE-miRNA for the detailed exploration of SNP-influenced TF binding in the regulatory regions of miRNA genes.

Future work on dPORE-miRNA will include the integration of new promoter sets as soon as they become available. In addition, we plan to update the database in a next iteration to include the latest genome build (HG19) and the newest available SNP mapping (dbSNP 132). We also plan to integrate further search interfaces to increase dPORE-miRNA's utility, e.g. enable comparisons between miRNA genes with regards to SNPs and TFs.

The database dPORE-miRNA, as presented here, complements existing repositories and represents an easy means to investigate the regulatory regions of specific miRNAs of interest for SNPs that potentially affect miRNA regulation and shows the specific effects on binding sites.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: The authors have no support or funding to report.

References

1. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835–840. [PMC free article] [PubMed]
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. [PubMed]
3. Bracht J, Hunter S, Eachus R, Weeks P, Pasquinelli AE. Trans-splicing and polyadenylation of let-7 microRNA primary transcripts. RNA. 2004;10:1586–1594. [PMC free article] [PubMed]
4. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 2004;10:1957–1966. [PMC free article] [PubMed]
5. Lee Y, Kim M, Han J, Yeom KH, Lee S, et al. MicroRNA genes are transcribed by RNA polymerase II. The EMBO Journal. 2004;23:4051–4060. [PMC free article] [PubMed]
6. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nature Structural & Molecular Biology. 2006;13:1097–1101. [PubMed]
7. Canella D, Praz V, Reina JH, Cousin P, Hernandez N. Defining the RNA polymerase III transcriptome: Genome-wide localization of the RNA polymerase III transcription machinery in human cells. Genome Research. 2010;20:710–721. [PMC free article] [PubMed]
8. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004;432:231–235. [PubMed]
9. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, et al. The Microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432:235–240. [PubMed]
10. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA. 2004;10:185–191. [PMC free article] [PubMed]
11. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415–419. [PubMed]
12. Rajewsky N. microRNA target predictions in animals. Nature Genetics. 2006;38(Suppl):S8–13. [PubMed]
13. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, et al. Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data. PLoS ONE. 2009;4:e5279. [PMC free article] [PubMed]
14. Fujita S, Iba H. Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates. Bioinformatics. 2008;24:303–308. [PubMed]
15. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008;134:521–533. [PMC free article] [PubMed]
16. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, et al. Chromatin structure analyses identify miRNA promoters. Genes & Development. 2008;22:3172–3183. [PMC free article] [PubMed]
17. Zhou X, Ruan J, Wang G, Zhang W. Characterization and Identification of MicroRNA Core Promoters in Four Model Species. PLoS Computational Biology. 2007;3:e37. [PMC free article] [PubMed]
18. Schmeier S, MacPherson CR, Essack M, Kaur M, Schaefer U, et al. Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation. BMC Genomics. 2009;10:595. [PMC free article] [PubMed]
19. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853–858. [PubMed]
20. Lau N, Lim L, Weinstein E, Bartel D. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858–862. [PubMed]
21. Lee Y, Jeon K, Lee JT, Kim S, Kim V. MicroRNA maturation: stepwise processing and subcellular localization. The EMBO Journal. 2002;21:4663–4670. [PMC free article] [PubMed]
22. Brookes AJ. The essence of SNPs. Gene. 1999;234:177–186. [PubMed]
23. Vignal A, Milan D, SanCristobal M, Eggen A. A review on SNP and other types of molecular markers and their use in animal genetics. Genetics, Selection, Evolution: GSE. 2002;34:275–305. [PMC free article] [PubMed]
24. Heckmann JM, Uwimpuhwe H, Ballo R, Kaur M, Bajic VB, et al. A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis. Genes and Immunity. 2010;11:1–10. [PMC free article] [PubMed]
25. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genetics. 2001;29:223–228. [PubMed]
26. Yue P, Moult J. Identification and analysis of deleterious human SNPs. Journal of Molecular Biology. 2006;356:1263–1274. [PubMed]
27. Kasowski M, Grubert F, Heffelfinger C, Hariharan M, Asabere A, et al. Variation in transcription factor binding among humans. Science. 2010;328:232–235. [PMC free article] [PubMed]
28. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, et al. PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Research. 2007;35:D51–54. [PMC free article] [PubMed]
29. Hariharan M, Scaria V, Brahmachari SK. dbSMR: A novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics. 2009;10:108. [PMC free article] [PubMed]
30. Conde L, Vaquerizas JM, Dopazo H, Arbiza L, Reumers J, et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Research. 2006;34:W621–625. [PMC free article] [PubMed]
31. Kim B, Kim W, Park D, Chung W, Shin K, et al. SNP@Promoter: A database of human SNPs (single nucleotide polymorphisms) within the putative promoter regions. BMC Bioinformatics. 2008;9(Suppl 1):S2. [PMC free article] [PubMed]
32. Alexiou P, Vergoulis T, Gleditzsch M, Prekas G, Dalamagas T, et al. miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Research. 2010;38:D137–D141. [PMC free article] [PubMed]
33. Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, et al. PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biology. 2010;11:R6. [PMC free article] [PubMed]
34. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG. The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Research. 2009;37:D155–158. [PMC free article] [PubMed]
35. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, et al. The UCSC Genome Browser database: update 2010. Nucleic Acids Research. 2010;38:D613–619. [PMC free article] [PubMed]
36. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Research. 2010;38:D5–16. [PMC free article] [PubMed]
37. Kel A, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis O, et al. MATCHTM: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Research. 2003;31:3576–3579. [PMC free article] [PubMed]
38. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Research. 2006;34:D108–110. [PMC free article] [PubMed]
39. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research. 2010;38:D355–360. [PMC free article] [PubMed]
40. Bandiera S, Hatem E, Lyonnet S, Henrion-Caude A. microRNAs in diseases: from candidate to modifier genes. Clinical Genetics. 2010;77:306–313. [PubMed]
41. Du L, Pertsemlidis A. microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Reviews. 2010;29:109–122. [PMC free article] [PubMed]
42. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nature Reviews. Immunology. 2010;10:111–122. [PubMed]
43. Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, et al. microRNA, cell cycle, and human breast cancer. The American Journal of Pathology. 2010;176:1058–1064. [PMC free article] [PubMed]
44. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. A census of human cancer genes. Nature Reviews. Cancer. 2004;4:177–183. [PMC free article] [PubMed]
45. Wang J, Lu M, Qiu C, Cui Q. TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Research. 2010;38:D119–122. [PMC free article] [PubMed]
46. Loeffler-Ragg J, Schwentner I, Sprinzl GM, Zwierzina H. EGFR inhibition as a therapy for head and neck squamous cell carcinoma. Expert Opinion on Investigational Drugs. 2008;17:1517–1531. [PubMed]
47. Milanezi F, Carvalho S, Schmitt FC. EGFR/HER2 in breast cancer: A biological approach for molecular diagnosis and therapy. Expert Review of Molecular Diagnostics. 2008;8:417–434. [PubMed]
48. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497–1500. [PubMed]
49. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401–1414. [PMC free article] [PubMed]
50. Li G, Miskimen KL, Wang Z, Xie XY, Brenzovich J, et al. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood. 2010;115:1416–1424. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...